Trial Profile
Study of symptom improvement effect of gastric acid suppressive drugs in reflux esophagitis patients -a randomized comparative study of vonoprazan vs esomeprazole -
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2017
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary) ; Esomeprazole
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 02 Nov 2017 Status changed from not yet recruiting to completed.
- 16 May 2016 New trial record